-
- I. S. Cheon
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
-
- C. Li
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
-
- Y. M. Son
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
-
- N. P. Goplen
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
-
- Y. Wu
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
-
- T. Cassmann
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
-
- Z. Wang
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
-
- X. Wei
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
-
- J. Tang
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
-
- Y. Li
- Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA.
-
- H. Marlow
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
-
- S. Hughes
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
-
- L. Hammel
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
-
- T. M. Cox
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
-
- E. Goddery
- Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
-
- K. Ayasoufi
- Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
-
- D. Weiskopf
- Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
-
- J. Boonyaratanakornkit
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
-
- H. Dong
- Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
-
- H. Li
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.
-
- R. Chakraborty
- Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
-
- A. J. Johnson
- Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
-
- E. Edell
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
-
- J. J. Taylor
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
-
- M. H. Kaplan
- Department of Microbiology and Immunology, Indiana University of School of Medicine, Indianapolis, IN 46202, USA.
-
- A. Sette
- Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
-
- B. J. Bartholmai
- Department of Radiology, Mayo Clinic, Rochester, MN 5590, USA.
-
- R. Kern
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
-
- R. Vassallo
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
-
- J. Sun
- Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
書誌事項
- 公開日
- 2021-11-26
- DOI
-
- 10.1126/sciimmunol.abk1741
- 公開者
- American Association for the Advancement of Science (AAAS)
説明
<jats:p> Respiratory tissue resident–like CD8 <jats:sup>+</jats:sup> T cells are associated with chronic lung sequelae post-acute COVID-19. </jats:p>
収録刊行物
-
- Science Immunology
-
Science Immunology 6 (65), eabk1741-, 2021-11-26
American Association for the Advancement of Science (AAAS)
